CLINICAL OUTCOMES SilverHawk™ Peripheral Plaque Excision System

DEFINITIVE LE Clinical Summary

The DEFINITIVE LE study is one of the largest multinational, multicenter PAD device studies to date, enrolling 800 patients from 47 sites in the United States and Europe. It provides insight into the clinical utility of directional atherectomy with the SilverHawk™ Directional Atherectomy Device in a broad range of patients, including diabetics, non-diabetics, claudicants, and those with critical limb ischemia (CLI).

Read more about the DEFINITIVE LE clinical study in published, peer-reviewed journals:

DEFINITIVE LE - acute
Acute Results of Directional Atherectomy for the Treatment of Claudication and Critical Limb Ischemia in the DEFINITIVE LE Study

DEFINITIVE LE - primary
Lower Extremity Revascularization Using Directional Atherectomy: 12-month Prospective Results of the DEFINITIVE LE Study

DEFINITIVE LE - infrapopliteal
One-year Outcomes Following Directional Atherectomy of Infrapopliteal Artery Lesions: Subgroup Results of the Prospective, Multicenter DEFINITIVE LE Trial

DEFINITIVE LE - diabetes
A Comparison of Clinical Outcomes for Diabetic and Nondiabetic Patients Following Directional Atherectomy in the DEFINITIVE LE Claudicant Cohort

DEFINITIVE Calcium
Effective Endovascular Treatment of Calcified Femoropopliteal Disease with Directional Atherectomy and Distal Embolic Protection: Final Results of the DEFINITIVE Ca⁺⁺ Trial

Downloads

Download these clinical paper reviews and learn more about DEFINITIVE LE results overall.

pdf DEFINITIVE LE 12-Month Prospective Results (.pdf)

Highlights from study to evaluate safety and effectiveness of directional atherectomy for treatment of peripheral arterial disease.

126KB

Document thumbnail
pdf DEFINITIVE LE 12-Month Infrapopliteal Results (.pdf)

Highlights from study to evaluate effectiveness of directional atherectomy for treatment of peripheral arterial disease in infrapopliteal lesions at one year.

132KB

Document thumbnail
pdf DEFINITIVE LE 12-Month Claudicant Diabetic Results (.pdf)

Highlights from DEFINITIVE LE subset analysis evaluating hypothesis that directional atherectomy for treatment of peripheral arterial disease in claudicants with diabetes has non-inferior primary patency at one year compared with claudicants without diabetes.

141KB

Document thumbnail

See product catalog for complete, detailed product information. 

This page may include information about products that may not be available in your region or country. Please consult the approved indications for use. Content on specific Medtronic products is not intended for users in markets that do not have authorisation for use.